UNSPSC 85251908: Diagnosis of malignant neoplasm on the overlapping malignant melanoma of skin

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Overlapping malignant melanoma of skin. Malignant neoplasm on the Overlapping malignant melanoma of skin is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C43. 8

UNSPSC 85251908 Diagnosis of malignant neoplasm on the overlapping malignant melanoma of skin is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific pathology diagnostic service—melanoma diagnosis—yet the three most recent state and local contract opportunities posted under this code span diagnostic imaging system implementation (San Mateo Medical Center), special education contracted services (Birdville Independent School District), and temporary health professional staffing (Santa Clara County Health System), none of which directly match the code's stated scope of melanoma diagnosis. This disconnect suggests either a data classification error in how these opportunities were tagged or that the code's application in state and local procurement systems does not reflect its clinical nomenclature.

The issuing bodies in recent activity include a county-run public hospital system in California, a large independent school district in Texas, and a county health system in California—a mix that does not point to cohesive demand for melanoma diagnosis services as a procured line item. Geographic activity appears limited to California and Texas based on the three available records. The single opportunity most proximate to clinical diagnostics—San Mateo Medical Center's PACS system RFP with a response date of October 21, 2026—is system infrastructure for radiology and imaging more broadly, not melanoma-specific diagnosis. Given the absence of recent solicitations actually requesting melanoma diagnostic services, pathology referrals, or related clinical protocols under this code, the code does not present a material procurement opportunity for vendors in this specialty at this time.